Archive for the ‘Canadian Drugs’ Category

Big Mountain Drugs Offers Discount Coupon and Safety Tips in Regarding to Prescription Medication

Monday, April 30th, 2012

Big Mountain Drugs is helping the green movement this week by offering a prescription drug coupon for everyone who recycles their unused prescriptions. The coupon code is valid for fifteen dollars off of any prescription, and is available for a week only. All new customers can use the coupon code rx15 to receive the discount on their medications. This coupon is particularly useful for customers who buy Lipitor, Advair, Plavix, and other daily prescription medications.

Multiple towns in Louisiana are providing special drop zones for customers to safely dispose of their unused prescription and over the counter medications. When unused medications expire, patients often flush them down the toilet, or dispose of them with their household garbage. What many people do not realize is that the flushed medications can enter the water system. There, they can be ingested by plants and animals, or taint the ground water supply. Be sure to safely dispose of your medications in the proper locations, just like a refrigerator or computer disposal. From there, you can buy your prescriptions with the confidence that you are not unduly affecting your environment.

With the constant turnover in your medicine cabinet, you may be noticing a financial burden. However, there are many ways to save on your medications. Buying generic medications is one of the best ways to save money on your prescriptions purchases. A generic is a medication that has an expired patent. Generic alternatives to expensive brand name medications such as generic Plavix and Lipitor are chemically and therapeutically the same as the brand-name original, but cost significantly less, as the manufacturer does not have to recoup expensive marketing, research, and development costs. Remember to also use coupons wherever possible. Buying online offers many more buying options, such as generic or brand name, or the availability of coupons.

Big Mountain Drugs, an online pharmacy based out of Vancouver, British Columbia, offers certified Canadian pharmacy care at lowered prices. Their mission is to provide safe and reliable medications to their customers. The Canadian pharmacy also partners with sites such as http://www.colchicine.ca/ to provide the most up-to-date information on gout treatment and medications; both brand Cocrys and generic Colchicine. Big Mountain Drugs offers well-known brand-name and generic medications such as generic Crestor, Motilium, Seroquel and Viagra. Big Mountain Drugs specializes in speedy, secure prescription deliveries right to you. They accept prescription and over the counter orders through fax, online orders, and over the phone. The Canadian drugs pharmacy is proud to offer their telephone service in multiple languages. Big Mountain Drugs is fully certified by PharmacyChecker.com, and is a member of the Canadian International Pharmacy Association (CIPA).

# # #
http://www.prweb.com/releases/prwebcanadiandrugs/bigmountain/prweb9444563.htm

Share

Canadian Invention Will Soon be Saving International Lives

Friday, April 6th, 2012

ITClamp

An Afghanistan war veteran has created a new tool for paramedics and trauma surgeons. Similar in shape to a woman’s “butterfly clip,” this clamp is designed to speedily close traumatic wounds. After winning the top innovator award at the Life Science and Health Care Ventures Summit in New York, Dr. Filips and his firm, Innovative Trauma Care (ITC), hope to launch this device later this year. Dr. Filips plans to launch the ITClamp to the Canadian military, US and possibly New Zealand and Australia.

The ITClamp stands for Innovative Trauma Care clamp. It was formerly known as the Tactical Use Skin Closure device. The ITClamp is a group of small curved needles which are embedded within the ‘arms’ of the spring-loaded device. The edges of the wound are pulled together, and up, then clamped together. This stops serious bleeding almost instantly. Because the edges of the wound are lifted, the blood doesn’t have a channel to flow through. This immediately slows bleeding.

Dr. Filips came up with the idea after seeing first hand the difficulties paramedics have with serious and often multiple trauma wounds. Using the ITClamp allows for the paramedics and trauma surgeons to close all the wounds, then choose which is the most life-threatening and work on that (often an abdominal wound). The clamp comes in one size, but for large wounds, doctors can use multiple ITClamps. Dr. Filips expects hospitals to stock around 6 ITClamps in ambulances, and ER doctors could have around 20 on hand in the emergency room. Innovative Trauma Care is currently manufacturing test devices to send to national approval centres such as the United States’ Food and Drug Administraion. They expect approval within 3 months.

For more information see the Province’s original story here.

Share

Warning: Statin Medications May Cause Diabetes and Memory Loss

Thursday, March 1st, 2012

Mixed statin box

Health regulators are adding more warnings to the labels of some of the most commonly prescribed statin medications, such as Lipitor and Zocor. The widely used medication will now warn the users that taking these medications may raise blood sugar levels and could cause memory loss.

On Tuesday the FDA announced the changes to the safety information on the labels of statins such as Pfizer Inc’s Lipitor, AstraZeneca’s Zocor. These medications are taken by ten of millions of people, and health officials are stating that this new information should not scare people into stopping taking the drugs.

Amy Egan, deputy director for safety in FDA’s Division of Metabolism and Endrocrinology Products, said in a statement regarding the new warnings, “The value of statins in preventing heart disease has been clearly established, their benefit is indisputable, but they need to be taken with care and knowledge of their side effects.”

A person with heart disease must be on a statin. Statin medications are responsible for saving more lives than almost any other medication, and this new revelation does not change the big picture, which is that Statin medication saves lives.

“These are nuances, tiny little tweaks to the lable,” said Steve Nissen, chief of cardiology at Cleveland clinic. “If you have heart disease, you probably should be on a statin. If you’re at high risk, a statin may be warranted. But we don’t think these drugs should be put in the water supply,” Nissen said.

When asked what prompted the label changes, FDA spokeswomen Erica Jefferson said they were based in the agency’s review of medical literature, clinical trial data and reports of adverse events.

“We have known for three or four years that statins slightly increase blood sugar,” Nissen said. “The fact that the blood sugar went up a little bit did not diminish the effectiveness of the statins in reducing (heart) risk for patients.”

It is important to remember to take this new information with a grain of salt and that any person who has heart disease be on and stay on a statin medication. It is however; also important to be informed about the medications you are taking, and fully understand the risks associated with that medication. Be sure to always speak with you health care professional to ensure that the benefits of taking your medication outweigh the risks.

Share

Stem Cells may Ease Some Types of Blindness

Friday, January 27th, 2012

stem cell therapy

Embryonic stem cells are often touted to be “the medication of the future.” A new study has just been released corroborating this idea, that stem cells may be used to cure or ease symptoms of previously untreatable conditions.

A new study, funded by Advanced Cell Technology in Massachusetts, has shown that stem cells may improve blindness caused by certain diseases. Not only does it lessen the blindness, stem cells also work quickly. After four months, neither of the participants had any negative immune responses, as is sometimes seen with stem cell introduction. Ideally, the stem cells could be used in earlier stages of treatment, potentially stopping symptoms in their tracks.

The two patients, a 78 year old woman with dry, age-related macular degeneration (the number one cause of blindness in the developed world), and a 51 year old woman with Stargardt’s macular dystrophy, had retinal cells replaced with embryonic stem cells. Stargardt’s is the most common cause of juvenile blindness. The 51 year old went from being unable to read a single to reading 5 after her treatment. The 78 year old went from reading 21 letters in a row to 28.

Stem cells are often considered a controversial treatment, as the uninformed mostly consider them to be taken from embryos (unborn children). Embryonic stem cells are found in the umbilical cord, and are reputed to be able to help stave off many illnesses once activated. The usefulness of a stem cell comes from its ability to grow into other cells. It could be considered the “template cell” for many other body cells. There are now even “banks” in which to keep preserved umbilical cords-essentially keeping a stock of cells that can be grown into other cells for any future mishaps. However, there are also adult stem cells, which can be found in many different types of tissue. Bone marrow transplants, which save thousands of leukemia patients yearly, are based in the transfer of stem cells from a viable donor to a patient.

This study is the first time that there has been information published on the outcome of an embryonic stem cell treatment. Judging by this outcome, we can see why they published it. It was noted in the study however, that researchers are unsure if the positive outcomes on the patients could have also been attributed to immunosuppressive agents or a placebo effect. This type of treatment will not be available to the public for some years, said the researcher, as there are many safety assessments to be completed.

Until such time as stem cell treatments are available outside of a human trial, we will have to use regular medications to treat our symptoms and conditions.

Share

Marijuana: An untapped source of prescription medications?

Monday, January 23rd, 2012

Sativex

Is marijuana a viable source of prescription medications? British company GW Pharma says yes. They have developed a mouth spray for use by cancer patients. It is currently in advanced clinical trials. GW Pharma hopes to market Sativex in the United
States for cancer pain treatment.

Sativex, is the first drug to be derived from raw marijuana, not synthetic equivalents. It contains cannabidiol and delta-9 THC, two of marijuana’s best known components.

Sativex has already been approved in Canada, New Zealand, eight other European countries for relieving muscle spasms in multiple sclerosis patients.

Resource link:
http://www.cbc.ca/news/health/story/2012/01/23/marijuana-drugs-gw-pharma.html

Share

Erectile Dysfunction Linked to Taking More Medications

Thursday, November 24th, 2011

from emaxhealth.com

In a Kaiser Permanente study, the more medications men are taking, the higher risk of their erectile dysfunction (ED). The study surveyed more than 37,000 ages 46 to 69, 29 percent of men had experienced moderate to severe ED problems.

The erectile dysfunction is the also known as impotence when some men has problems achieving or maintaining an erection. Erectile dysfunction can occur or affect men of any age; especially it is common in the elderly. An estimate of 30 million in the US has suffered this embarrassing condition, according to MedicineNet.com.

Medications and ED
It is still not fully understood how taking more medications may increase the risk of ED. But the evidences showed the number of medications men took increased, so did the severity of their erectile dysfunction.

Medications —— Number of Men ——-  Moderate ED
0-2 ———————- 16,126 ——————— 15.9%
3-5  ——————— 10,046 ——————— 19.7%
6-9  ———————-  6,870 ——————— 25.5%
>10  ———————- 4,670 ——————— 30.9%

ED problem can be caused by a variety of factors, including age, depression, diabetes, high cholesterol, hypertension, and smoking history. The pharmacy records showed medications the most commonly prescribed with ED, including antihypertensives (beta blockers, thiazides, and clonidine) and antidepressants (selective serotonin reuptake inhibitors, tricyclics, MAO inhibitors).

Men with ED problems need to speak to the doctors to review the medications they are taking and the potential side effects. A prescription is required for any RX drugs including erection dysfunction medications such as Viagra, Cialis, and Levitra.

Share

New Legislation increases Threat to your Health

Monday, November 21st, 2011

— Your Right to Order Prescriptions Online is in Danger —

Misguided efforts by Congress and officials in the White House during the past two years could take away Americans’ ability to order medications online — even from trusted and reputable sources like our website. There are two real and imminent threats to continued access to safe, imported prescription drugs.

The first threat comes from pending legislation in the Senate introduced last May known as the Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 (PROTECT IP). You may already be aware of this Bill that attempts to categorize all non-U.S. based online pharmacies as a risk to public health and therefore certain target for shut down. If this bill gets passed, our website and all others that sell Canadian drugs and international medicines to Americans could cease to appear and be prohibited from defending themselves against those who shut them down.

The next threat comes from The House of Representatives in a bill introduced in October titled the Stop Online Piracy Act (SOPA). While SOPA is designed to protect the interests of U.S. businesses and fight counterfeiting, it increases the threatening actions proposed in PROTECT IP and makes them worse. SOPA includes language that inappropriately lumps real licensed pharmacies like ours with rogues.

SOPA makes no effort to distinguish between the good guys like us – legitimate pharmacies that require a doctor’s prescription and sell brand-name medications; and the bad guys – that sell everything from diluted or counterfeit medicine to narcotics without a prescription. Because of this, the bill could shut down the websites of legitimate international pharmacies that offer safe, affordable medications.

The language of SOPA is so vague and broad, that our pharmacy could be shut-down “in the dark of night.” You see, SOPA grants legal immunity to a large list of US companies that have business reasons for wanting us dismantled. They can voluntarily deny service to our legitimate pharmacy businesses without a court order. It empowers hundreds of companies to police the web and shut-down sites based on nothing more than a suspicion of wrongdoing.

PROTECT IP and SOPA are driving legislation toward the White House. These bills play directly into the interests of the Administration, which in December 2010 announced its intention to completely shut down online pharmacy sites by “encouraging” Internet service providers, credit card companies, and search engines to cut off American’s access to them. Passage of these two bills would fulfill this mission.

Many people believe that big pharmaceutical companies are behind these threats. Major drug companies have long tried to persuade the American public that internationally sourced medicines are unsafe. While we agree that drug safety is critical and that rogue pharmacies should be stopped we know that legitimate online pharmacies such as ours should not be punished as a result of these sweeping actions.

There is action you can take to try to prevent this from happening— and we are asking for everyone’s assistance immediately. To voice your concern, join RxRights, a growing coalition of individuals and organizations that are dedicated to protecting and preserving all Americans’ access to safe, affordable medications. You can send an electronic letter directly to your congressional and senate representatives in Washington as well as President Obama through the coalition’s website at www.rxrights.org. Let your elected officials know today that you want and need continued access to affordable medications from safe, licensed online pharmacies like ours. For more information, please visit www.rxrights.org.

Share

Blockbuster Statin Drugs Square Off In Clinical Trial

Tuesday, November 1st, 2011

from Mercola Natural Health

An embarrassed Astra-Zeneca just lost a very public “smack down” with rival drug maker Pfizer. Both consumers and the pharmaceutical industry were anxiously awaiting the results of the pharmaceutical equivalent of the “fight of the century” – a toe-to-toe match between blockbuster cholesterol reducing drugs Crestor and Lipitor.

But in the just-announced trial results, Crestor failed to clearly best Lipitor at clearing clogged arteries. Although it did demonstrate what Astra-Zeneca called a “numerically greater” effect, it did not achieve the statistical significance that would have provided the cholesterol drug with an obvious victory.

The researchers measured the amount of plaque in two different ways, by total volume and percentage volume. Crestor reduced the total volume of fatty deposits in the artery more than Lipitor, but on a percentage basis – the study’s chief measure of effectiveness – the result wasn’t a knock-out.

Pharmaceutical giant AstraZeneca was so convinced of its cholesterol drug’s superiority that it sponsored the clinical trial, called the Saturn study. Crestor is generally considered the more effective of the cholesterol medications, and past trials suggested that high doses of Crestor could beat high doses of Lipitor at reducing levels of “bad” LDL cholesterol and increasing levels of “good” HDL cholesterol.

Shares in AstraZeneca fell upon news of its discomforting failure to best its rival. The timing of this clinical study was critical, as Lipitor is about to go off-patent at the end of 2011, allowing other drug companies to market it as cheaper generic atorvastin. Had Crestor proved the victor in the head-to-head battle, its loss of market share to the cheaper generic Lipitor would have been greatly reduced.

But the calculated risk failed to pay off, and there is now little incentive for doctors to prescribe, and patients to pay extra money for, the pricy patented cholesterol drug. The results threaten to topple Crestor’s champion status as Astra-Zeneca’s biggest-selling drug, with US sales of $2.64 billion in 2010.

Rival Lipitor was the second top-selling prescription drug in the US in 2010 (behind Nexium and followed by Plavix). Crestor lagged behind in ninth place. Lipitor is a top-seller across the world. Generic Lipitor has been available in Canada since early 2011, making cheap Lipitor from Canada available to Americans through online Canadian pharmacies.

Both Crestor and Lipitor are statins. A statin is a cholesterol-lowering drug that reduces LDL cholesterol by reducing the liver’s ability to make cholesterol, and by helping the body to reabsorb cholesterol plaque that has accumulated on the artery walls. High cholesterol is a major risk factor for heart attack and stroke.

Share

Study Uncovers New Uses for Old Drugs

Thursday, October 27th, 2011

from rhome_music

A team from the Stanford University School of Medicine used an approach inspired by online dating to identify potential new uses for existing medications. The researchers developed a computer program to compare disease symptoms against the known medicinal properties of commonly used generic drugs to find an effective “match”.

The research team created a program that searched the National Institutes of Health’s (NIH) databases at lightning speed, comparing the results of genetic studies. They looked for cases where a change in gene activity caused by a drug was the opposite to the gene activity caused by a disease. The assumption was that creating the opposite effect to that caused by a disease might result in an effective treatment.

Scouring the data on 100 diseases and 164 generic drugs, the computer correctly matched drugs to the conditions they are already used to treat, and came up with possible new drug “relationships” for 53 of the 100 conditions. All together, it identified 1000 pharmaceuticals with the potential to be repurposed as new treatments.

The most promising matches – an ulcer drug (Tagamet) that may be effective against lung cancer, and an epilepsy drug (Topamax) that could treat inflammatory bowel disease – were then tested in animal studies with positive results.

There are a number of advantages to repurposing drugs that are already FDA-approved: they don’t require a huge investment in research and development; their safety and possible side effects are already established; doctors can prescribe them off-label; and the patent has expired on many of them, so they are available as cheaper generic drugs.

There is, however, one major stumbling block – generic drugs are not big money makers for the pharmaceutical companies, and there is little incentive for them to pursue additional uses for them unless they can be rebranded and patented.

“If there are additional uses for prescription drugs coming off patent, one could be thinking creatively – how do we find the value in that?” said Atul Butte, an associate professor of systems medicine who headed up the study, “Unless someone focuses on this, the additional uses are never going to be captured. Companies have to get creative and remarket and rebrand these to test in clinical trials.”

The NIH has been educating academics, politicians and drug companies on repurposing drugs more effectively, and is searching for abandoned drugs that could be recycled for other than the original purposes. This dovetails with the federal government’s push to cut drug costs to bring prices more in line with those in other countries, for example drugs from Canada.

The classic example of a drug that was successfully repurposed is the erectile dysfunction medication Viagra, which was originally developed to treat chest pain. AZT, originally investigated to fight cancer, turned out to be a major breakthrough in HIV/AIDS treatment.

Share

E-Medicine Transforms the Health Landscape

Wednesday, October 12th, 2011

According to the Pew Research Center’s Internet and American Life Project, technologies like social networking sites and smart phones have transformed the way people receive and share health care information over the last ten years.

Susannah Fox, Associate Director of Digital Strategy for the Pew Research Centre Internet and American Life Project and keynote speaker at this year’s Medicine 2.0 Conference at Stanford University, calls the phenomenon “peer-to-peer health care.”

“So many people are listening to each other and learning from each other, and not just from institutions,” says Fox, who describes herself as an “internet geologist” mining information. Fox has unearthed two key trends, which she calls:

1) The mobile difference: “If you hand someone a smart phone, they’re more likely to share; they’re more likely to create content and not just consume it.”

2) The diagnosis difference: “An internet user who is living with a chronic disease is more likely to both create and consume user-generated content related to health.”

A survey of over 3000 people conducted by the Pew Research Center showed that, while health care professionals remained the number one resource for those with health concerns, online resources, including peers, are a significant and growing source of health information.

Of the 74% of adults who use the internet, 80% of them have looked online for health information. People are searching the internet for reviews on diseases and conditions, medical treatments, prescription drugs, online pharmacies, doctors, hospitals and clinics.

Many also look for others with the same health concern or experience. Over one third of those surveyed (35%) have read another person’s comments or experiences on health or medical issues on a website, blog, or newsgroup – a concept Fox calls “participatory medicine”.

This trend has spawned innumerable niche websites dealing with both general and specific health conditions, some of them more authoritative than others. Many allow visitors to comment and to interact on discussion boards and online forums.

The trend has also created a surge in the use of online pharmacies. The most obvious reasons are significantly lower prices and convenience – customers simply order their prescription medications online, and they’re delivered to their door. Online pharmacies also offer anonymity to those who may not want their local pharmacist to know they are taking HIV medication, antidepressants or Viagra.

Online Canadian pharmacies are the most popular with Americans. Drugs from Canada are cheaper because the government regulates their prices; allows manufacturers to produce cheaper but chemically identical generic versions sooner, and does not allow drug companies to engage in expensive direct to consumer advertising.

Of course internet health consumers must be aware that anyone can post pretty much anything online, and there is a lot of misleading information and misinformation out there. Also bear in mind that some information posted years ago may be outdated. But according to the Pew Research Center’s Internet and American Life Project, most people (97%) report being helped rather than harmed by health information they found online.

Share